GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abera Bioscience AB (XSAT:ABERA) » Definitions » Loans Receivable

Abera Bioscience AB (XSAT:ABERA) Loans Receivable : kr0.00 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Abera Bioscience AB Loans Receivable?

Abera Bioscience AB's Loans Receivable for the quarter that ended in Jun. 2024 was kr0.00 Mil.


Abera Bioscience AB Loans Receivable Historical Data

The historical data trend for Abera Bioscience AB's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abera Bioscience AB Loans Receivable Chart

Abera Bioscience AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial - - - - -

Abera Bioscience AB Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Abera Bioscience AB Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Abera Bioscience AB Loans Receivable Related Terms

Thank you for viewing the detailed overview of Abera Bioscience AB's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Abera Bioscience AB Business Description

Traded in Other Exchanges
N/A
Address
Svetsarvagen 15, Solna, SWE, SE-17141
Abera Bioscience AB is a platform and vaccine development company based on research in the medical, molecular, and microbiological fields. The company's mission is to develop vaccine candidates based on its novel vaccine delivery platform to late pre-clinical or early clinical phase.

Abera Bioscience AB Headlines

No Headlines